Citation Impact
Citing Papers
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
2000 Standout
Portosystemic Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt in Patients With Cirrhosis: Clinical, Laboratory, Psychometric, and Electroencephalographic Investigations
1998
Neuropsychological Characterization and Detection of Subclinical Hepatic Encephalopathy
1996
Hepatic Disorders
1995
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Screening of subclinical hepatic encephalopathy
2000
ESPEN guideline: Clinical nutrition in surgery
2017 Standout
Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis
2010
Subclinical hepatic encephalopathy impairs daily functioning
1998
Branched-chain amino acids and ammonia metabolism in liver disease: Therapeutic implications
2013
Review article: the burden of hepatic encephalopathy
2007
Treatment of Hepatic Encephalopathy
1997
Clinical Features and Survivial of Cirrhotic Patients With Subclinical Cognitive Alterations Detected by the Number Connection Test and Computerized Psychometric Tests
1999
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Neurophysiological assessment of early hepatic encephalopathy
1990
ESPEN Guidelines on Enteral Nutrition: Surgery including Organ Transplantation
2006 Standout
Methods for Diagnosing Hepatic Encephalopathy in Patients with Cirrhosis: A Multidimensional Approach
2004
The Multi-Dimensional Burden of Cirrhosis and Hepatic Encephalopathy on Patients and Caregivers
2011
ESPEN guidelines for nutrition in liver disease and transplantation
1997
Secondary Prophylaxis of Hepatic Encephalopathy: An Open-Label Randomized Controlled Trial of Lactulose Versus Placebo
2009
Neuropsychological characterization of hepatic encephalopathy
2001
Characteristics of Minimal Hepatic Encephalopathy
2004
Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”
2010 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Critical flicker frequency for quantification of low-grade hepatic encephalopathy
2002
Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines
2009
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy
2022
Psychiatric Aspects of Portal-Systemic Encephalopathy
1998
Probiotic Yogurt for the Treatment of Minimal Hepatic Encephalopathy
2008
Cachexia in liver cirrhosis
2002
Neurological and neuropsychiatric syndromes associated with liver disease
2005
Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis
2004
Auditory P300 event‐related potentials and number connection test for evaluation of subclinical hepatic encephalopathy in patients with cirrhosis of the liver: A follow‐up study
2001
Study on the Sternberg Paradigm in Cirrhotic Patients Without Overt Hepatic Encephalopathy
1998
Review article: the design of clinical trials in hepatic encephalopathy - an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement
2011
Global burden of liver disease: 2023 update
2023 Standout
Branched-Chain Amino Acid Supplementation in Patients with Liver Diseases
2005
Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy
2001
Branched‐Chain‐Enriched Amino Acid Solutions in Patients with Liver Failure: An Early Example of Nutritional Pharmacology
1990
Rifaximin Improves Driving Simulator Performance in a Randomized Trial of Patients With Minimal Hepatic Encephalopathy
2010
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient:
2009 Standout
Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis
2009
Critical flicker frequency: Diagnostic tool for minimal hepatic encephalopathy
2007
Rifaximin Improves Psychometric Performance and Health-Related Quality of Life in Patients With Minimal Hepatic Encephalopathy (The RIME Trial)
2010
Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy
2011
Branched-Chain Amino Acid Enriched Supplements as Therapy for Liver Disease
2006
Nutritional support in patients with chronic liver disease
2006
Oral Branched-Chain Amino Acids Have a Beneficial Effect on Manifestations of Hepatic Encephalopathy in a Systematic Review with Meta-Analyses of Randomized Controlled Trials
2013
A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy
2011
Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998
2002 Standout
Visual attention in cirrhotic patients: A study on covert visual attention orienting
1998
Diagnostic tools for the detection of subclinical hepatic encephalopathy: comparison of standard and computerized psychometric tests with spectral-EEG
1996
Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations
2004
Minimal Hepatic Encephalopathy and Driving: Is the Genie Out of the Bottle?
2011
Management of Crohn's Disease in Adults
2009 Standout
The Transjugular Intrahepatic Portosystemic Stent-Shunt Procedure for Variceal Bleeding
1994
Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy. A comparative study of 154 patients with liver disease
2011
Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial
2003
Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy
2007
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis
1986
Gut Microbiota in Health and Disease
2010 Standout
Changing concepts of nutrient requirements in disease: implications for artificial nutritional support
1995
Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients
1993 Standout
Cerebral CT scan abnormalities in cholestatic and hepatocellular disease and their relationship to neuropsychologic test performance
1987
The effect of L-ornithine L-aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutrition.
2011
The antioxidant and free radical scavenging activities of processed cowpea (Vigna unguiculata (L.) Walp.) seed extracts
2006 Standout
Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.
2006 Standout
Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
2021
Role of Nutrition in the Management of Hepatic Encephalopathy in End-Stage Liver Failure
2010
Reduced neuropsychological test performance in asymptomatic carotid stenosis
2004
An Updated Definition of Stroke for the 21st Century
2013 Standout
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy
1993
Bio-Functional Legumes with Nutraceutical, Pharmaceutical, and Industrial Uses
2003
ESPGHAN and ESPEN Guidelines Paediatric Parenteral Nutrition ‐ Annex: List of Products
2005 Standout
A randomized double blind placebo controlled trial of probiotics in minimal hepatic encephalopathy
2011
Works of W. Hamster being referenced
Neuropsychological Aspects of Portal-Systemic Encephalopathy
1998
Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids
1993
Quality of Life in Cirrhotics with Minimal Hepatic Encephalopathy
2001
Branched Chain Amino Acids in the Treatment of Latent Portosystemic Encephalopathy
1985
Neuropsychological changes associated with stenoses or occlusions of the carotid arteries
1984
Latent portasystemic encephalopathy
1981